Brendan J. Nolan

Studley Road
Heidelberg, VIC 3084, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

All-cause and cause-specific mortality among transgender and gender diverse people: a nationwide cohort study in Australia.

All-cause and cause-specific mortality among transgender and gender diverse people: a nationwide cohort study in Australia.

Journal: The Lancet regional health. Western Pacific

Published: October 13, 2025

Mental health treatment among transgender and gender diverse people following gender affirming hormone therapy: evidence from whole-of-population Australian administrative data.

Mental health treatment among transgender and gender diverse people following gender affirming hormone therapy: evidence from whole-of-population Australian administrative data.

Journal: EClinicalMedicine

Published: September 21, 2025

Healthcare Costs Following Medical Gender-Affirmation: Evidence From Whole-of-Population Australian Administrative Data.

Healthcare Costs Following Medical Gender-Affirmation: Evidence From Whole-of-Population Australian Administrative Data.

Journal: Health economics

Published: August 22, 2025

Initiation and Maintenance of Low-Dose Transdermal Testosterone in Non-Binary Individuals: A Retrospective Audit.

Initiation and Maintenance of Low-Dose Transdermal Testosterone in Non-Binary Individuals: A Retrospective Audit.

Journal: Clinical endocrinology

Published: August 15, 2025

Temporal trends in gender-affirming hormone therapy initiation: evidence from whole-of-population Australian administrative data.

Temporal trends in gender-affirming hormone therapy initiation: evidence from whole-of-population Australian administrative data.

Journal: Internal medicine journal

Published: June 02, 2025

Approach to prolactin monitoring and hyperprolactinaemia in transgender and gender-diverse individuals undergoing gender affirming hormone therapy.

Approach to prolactin monitoring and hyperprolactinaemia in transgender and gender-diverse individuals undergoing gender affirming hormone therapy.

Journal: Frontiers in endocrinology

Published: April 08, 2025

Author reply to McDonough.

Author reply to McDonough.

Journal: Internal medicine journal

Published: March 02, 2025

Serum Estradiol Concentrations With Estradiol 0.06% Gel in Transgender and Gender-Diverse Adults.

Serum Estradiol Concentrations With Estradiol 0.06% Gel in Transgender and Gender-Diverse Adults.

Journal: Clinical endocrinology

Published: November 15, 2024

Testosterone and Quality of Life in Transgender and Gender-Diverse Adults Seeking Masculinization: A Secondary Analysis of a Randomized Clinical Trial.

Testosterone and Quality of Life in Transgender and Gender-Diverse Adults Seeking Masculinization: A Secondary Analysis of a Randomized Clinical Trial.

Journal: JAMA network open

Published: October 25, 2024

Giant Intracranial Meningiomas Requiring Surgery in 2 Transgender Women Treated With Cyproterone Acetate.

Giant Intracranial Meningiomas Requiring Surgery in 2 Transgender Women Treated With Cyproterone Acetate.

Journal: JCEM case reports

Published: July 16, 2024

Effect of bicalutamide on serum total testosterone concentration in transgender adults: a case series.

Effect of bicalutamide on serum total testosterone concentration in transgender adults: a case series.

Journal: Therapeutic advances in endocrinology and metabolism

Published: July 05, 2024

Gender-affirming hormone therapy for transgender and gender-diverse adults in Australia.

Gender-affirming hormone therapy for transgender and gender-diverse adults in Australia.

Journal: Internal medicine journal

Published: April 02, 2024

Showing 1-12 of 43

Last Updated: 09/26/2026